Skip to main content
Fig. 2 | Journal of Biomedical Science

Fig. 2

From: MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway

Fig. 2

miR-138-1-3p sensitized HCC cells to sorafenib. A and B qRT-PCR was conducted to determine the transfection efficiency of miR-138-1-3p inhibitor and mimics in Hep3B and HepG2 cells. C and D The cell viability and flow cytometric analysis were used to assess the influence of miR-138-1-3p overexpression or knockdown on cell viability and apoptosis in Hep3B and HepG2 cells

Back to article page